Gallmetzer Healthcare Valuation Multiples

Gallmetzer Healthcare is valued at $56M as of November 2026, a 1.0x revenue multiple. In the last fiscal year, Gallmetzer Healthcare revenue was $65M and Gallmetzer Healthcare EBITDA was $990K.

Gallmetzer Healthcare Overview

About Gallmetzer Healthcare

Gallmetzer Healthcare is the parent company of a group of dental, pharma and healthcare businesses based in Bolzano, Italy. Its portfolio includes Gerhò, a supplier of dental products for practices and laboratories with a range of more than 40,000 items, Promis, a maker of natural and organic oral care products, and Intermedical Pharma, a player in dental anesthesia. The group says it has more than 30 years of market experience and works across research, development, production and distribution. Its shares have traded on the Vienna Stock Exchange in the direct market plus segment since December 2025. Customers are dentists, dental laboratories and healthcare practices.


Founded

N/A

HQ

Italy

Employees

N/A

Financials (Last FY)

Revenue: $65M
EBITDA: $990K

EV

$66M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Gallmetzer Healthcare Financials

Gallmetzer Healthcare reported last fiscal year revenue of $65M and EBITDA of $990K.

In the same fiscal year, Gallmetzer Healthcare generated $10M in gross profit, $990K in EBITDA, and had net loss of ($611K).


Gallmetzer Healthcare P&L

In the most recent fiscal year, Gallmetzer Healthcare reported revenue of $65M and EBITDA of $990K.

Gallmetzer Healthcare is unprofitable as of last fiscal year, with gross margin of 15%, EBITDA margin of 2%, and net margin of (1%).

See analyst estimates for Gallmetzer Healthcare
Last FY2025202620272028
Revenue$65M$65M
Gross Profit$10M$10M
Gross Margin15%15%
EBITDA$990K$990K
EBITDA Margin2%2%
EBIT Margin0%0%
Net Profit($611K)($611K)
Net Margin(1%)(1%)
Net Debt$10M-

Financial data powered by Morningstar, Inc.

Gallmetzer Healthcare Stock Performance

Gallmetzer Healthcare has current market cap of $56M, and enterprise value of $66M.

Market Cap Evolution


Gallmetzer Healthcare's stock price is $3.48.

Gallmetzer Healthcare share price decreased by 9.1% in the last 30 days.

Gallmetzer Healthcare has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Gallmetzer Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$66M$56M-0.1%-9.1%-13.3%-$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Gallmetzer Healthcare Valuation Multiples

Gallmetzer Healthcare trades at 1.0x EV/Revenue multiple, and 66.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Gallmetzer Healthcare

Gallmetzer Healthcare Financial Valuation Multiples

As of November 19, 2026, Gallmetzer Healthcare has market cap of $56M and EV of $66M.

Gallmetzer Healthcare has a P/E ratio of (91.0x).

Last FY2025202620272028
EV/Revenue1.0x1.0x
EV/EBITDA66.3x66.3x
EV/EBITn/mn/m
EV/Gross Profit6.8x6.8x
P/E(91.0x)(91.0x)
EV/FCFn/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Gallmetzer Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Gallmetzer Healthcare Margins & Growth Rates

In the most recent fiscal year, Gallmetzer Healthcare reported gross margin of 15%, EBITDA margin of 2%, and net margin of (1%).

See estimated margins and future growth rates for Gallmetzer Healthcare

Gallmetzer Healthcare Margins

Last FY2025202720282029
Gross Margin15%15%
EBITDA Margin2%2%
EBIT Margin0%0%
Net Margin(1%)(1%)
FCF Margin(0%)(0%)

Gallmetzer Healthcare Growth Rates

25/2626/2727/2828/29
EBITDA Growth44%
Net Profit Growth(100%)
FCF Growth(679%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Gallmetzer Healthcare Operational KPIs

Access forward-looking KPIs for Gallmetzer Healthcare
Last FY2025202620272028
S&M Expenses to Revenue0%0%
G&A Expenses to Revenue2%2%
Opex to Revenue15%15%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Gallmetzer Healthcare Competitors

Gallmetzer Healthcare competitors include Bonus BioGroup, Boundless Bio, Corbus Pharmaceuticals, Tonix Pharmaceuticals, Agronomics, Milestone Pharmaceuticals, Cognition Therapeutics, XSpray Pharma, OKYO Pharma and LTR Pharma.

Most Gallmetzer Healthcare public comparables operate across Biopharmaceuticals and Medical Supplies.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Bonus BioGroup-($6M)--(9.1x)-
Boundless Bio-($62M)----
Corbus Pharmaceuticals-($84M)----
Tonix Pharmaceuticals$13M($126M)----
Agronomics($16M)($45M)(3.5x)-(1.2x)-
Milestone Pharmaceuticals$2M($62M)6.3x2.2x(0.2x)-
Cognition Therapeutics-($23M)--(1.2x)-
XSpray Pharma-($15M)-30.8x(3.6x)(4.2x)

This data is available for Pro users. Sign up to see all Gallmetzer Healthcare competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Gallmetzer Healthcare

Where is Gallmetzer Healthcare headquartered?Gallmetzer Healthcare is headquartered in Italy.
Is Gallmetzer Healthcare publicly listed?Yes, Gallmetzer Healthcare is a public company listed on Wiener Börse.
What is the stock symbol of Gallmetzer Healthcare?Gallmetzer Healthcare trades under GHC ticker.
When did Gallmetzer Healthcare go public?Gallmetzer Healthcare went public in 2025.
Who are competitors of Gallmetzer Healthcare?Gallmetzer Healthcare main competitors include Bonus BioGroup, Boundless Bio, Corbus Pharmaceuticals, Tonix Pharmaceuticals, Agronomics, Milestone Pharmaceuticals, Cognition Therapeutics, XSpray Pharma, OKYO Pharma, LTR Pharma.
What is the current market cap of Gallmetzer Healthcare?Gallmetzer Healthcare's current market cap is $56M.
What is the current revenue of Gallmetzer Healthcare?Gallmetzer Healthcare's last fiscal year revenue is $65M.
What is the current EV/Revenue multiple of Gallmetzer Healthcare?Current revenue multiple of Gallmetzer Healthcare is 1.0x.
Is Gallmetzer Healthcare profitable?No, Gallmetzer Healthcare is not profitable.
How many companies Gallmetzer Healthcare has acquired to date?Gallmetzer Healthcare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Gallmetzer Healthcare has invested to date?Gallmetzer Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Gallmetzer Healthcare

Lists including Gallmetzer Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial